Yong Yi
-
- Cancer, Hypoxia, and Metabolism 4
-
- Cancer-related Molecular Pathways 11
-
- Ubiquitin and proteasome pathways 9
- Metabolism, Diabetes, and Cancer 6
- Epigenetics and DNA Methylation 3
- PI3K/AKT/mTOR signaling in cancer 3
- RNA modifications and cancer 3
-
- Autophagy in Disease and Therapy 3
- Cited by
- Cancer ResearchGeneticsOncology
- Journals
- Nature Communications (3 papers)Journal of Cancer (3 papers)Cell Death and Differentiation (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Yong Yi
25 papers receiving 497 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 107
- Genetics 63
- Oncology 141
- Molecular Biology 348
- Cell Biology 55
Countries citing papers authored by Yong Yi
This map shows the geographic impact of Yong Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Yi more than expected).
Fields of papers citing papers by Yong Yi
This network shows the impact of papers produced by Yong Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Yi. The network helps show where Yong Yi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yong Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 10 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 15 | |
| 7 | 2024 | 12 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 14 | |
| 10 | 2023 | 11 | |
| 11 | 2022 | 38 | |
| 12 | 2021 | 8 | |
| 13 | 2020 | 19 | |
| 14 | 2020 | 55 | |
| 15 | 2019 | 36 | |
| 16 | 2018 | 24 | |
| 17 | 2017 | 18 | |
| 18 | 2017 | 32 | |
| 19 | 2013 | 15 | |
| 20 | 2012 | 13 |
About Yong Yi
Yong Yi is a scholar working on Oncology, Molecular Biology and Rehabilitation, having authored 28 papers that have together received 499 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Ubiquitin and proteasome pathways (9 papers), Metabolism, Diabetes, and Cancer (6 papers), Cancer, Hypoxia, and Metabolism (4 papers), Epigenetics and DNA Methylation (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Autophagy in Disease and Therapy (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (107 citations), Genetics (63 citations) and Oncology (141 citations). Yong Yi has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Zhi‐Xiong Jim Xiao, Mengmeng Niu, Yujun Zhang, Juan Ao, Hu Chen, Wenhua Zhang, Junjie Fei, Fengtian Li, Yang Wang and Yue Luo. Their work appears in journals such as Nature Communications, Journal of Cancer, Cell Death and Differentiation, Journal of Biological Chemistry and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.